False
December 3, 2025
Thermo Fisher Scientific
In this webinar, you’ll see real time-and-motion data comparing two NGS workflows (amplicon based Oncomine Dx Express Test* and hybrid capture based NGS workflow) for routine precision oncology,
6:00 pm - 7:00 pm GMT min
November 12, 2025
GE Healthcare
Pathology is changing. And not just a little—it’s undergoing a transformation that will define the future of healthcare.
1:00 pm - 2:00 pm GMT min
November 6, 2025
Thermo Fisher Scientific
Join us for an illuminating webinar titled "Advancing biomarker detection in lymphoid malignancies: Insights from leading scientists," where we bring together two of the foremost authorities in the field of haemato-oncology.
8.00 AM PDT | 4.00 PM GMT | 5.00 PM CET min
October 23, 2025
Thermo Fisher Scientific
Rapid comprehensive genomic profiling (CGP) is crucial for gaining important insights when timely results matter.
4:00 pm - 5:00 pm BST min
September 23, 2025
Illumina
TruSight™ Oncology 500 v2 (TSO500v2) is an updated next-generation sequencing (NGS) assay designed to enable laboratories with in-house comprehensive genomic profiling (CGP) from formalin-fixed, paraffin-embedded (FFPE) tissue samples.
12:00 pm - 1:00 pm GMT-4 min
September 3, 2025
Qiagen
Somatic mutations are key drivers in tumorigenesis and serve as critical diagnostic, prognostic, and predictive biomarkers.
10:00 am - 11:00 am GMT-4 min
December 10, 2024
Thermo Fisher Scientific
Evaluation of the Oncomine Comprehensive Assay Plus for comprehensive genomic profiling including homologous recombination deficiency assessment.
December 9, 2024
Owkin
Join expert panelists as we dive into results of a recent Owkin survey aimed at taking the temperature of pathologists and oncologists on the state of the field of pathology in the US, UK and France.
November 26, 2024
Illumina
The MiSeq™ i100 Series is the latest bench top sequencer from Illumina. It delivers breakthrough simplicity, our fastest run times yet, comprehensive analysis, and significant sustainability advancements.
October 28, 2024
Labcorp
Next-generation sequencing (NGS) is a cornerstone of precision oncology, providing critical insights for the accurate diagnosis and tailored treatment of various cancers.
Dive deeper into the world of pathology. Explore the latest articles, case studies, expert insights, and groundbreaking research.
False